The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescripti ...

President Donald Trump's executive order aims to eliminate private-sector middlemen from U.S. drug price negotiations, ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

Davis Selected Advisers’ 13F portfolio value increased to $17.35B, with the number of holdings rising from 100 to 104. Learn ...

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

Blue-chip health insurer UnitedHealth (UNH) is weighing on the Dow today after a suspended guidance and C-suite shakeup ...

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...